The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research
ND McKenzie, H Hong, S Ahmad… - Critical Reviews in …, 2021 - Elsevier
Investigation of the gynecologic tract microbial milieu has revealed potential new
biomarkers. Simultaneously, immunotherapeutics are establishing their place in the …
biomarkers. Simultaneously, immunotherapeutics are establishing their place in the …
SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7
PA Bousquet, D Manna, JA Sandvik… - Frontiers in …, 2022 - frontiersin.org
Cancer immunotherapy represents a promising approach to specifically target and treat
cancer. The most common mechanisms by which monoclonal antibodies kill cells include …
cancer. The most common mechanisms by which monoclonal antibodies kill cells include …
OPEN ACCESS EDITED BY
C Sautes-Fridman, L Xia, MI Hepp, J Ding… - Insights in cancer …, 2023 - books.google.com
Over the past decade, immunotherapy, such as immune checkpoint and CAR T cell therapy,
has become a promising strategy for treating cancer (1, 2). Cancer treatment is achieved by …
has become a promising strategy for treating cancer (1, 2). Cancer treatment is achieved by …